PRODUCT MONOGRAPH. Pr. JEVTANA. ®. Cabazitaxel for injection. Concentrated Solution 40 mg/mL. (60 mg/ mL). Antineoplastic Agent. JEVTANA in combination with prednisone or prednisolone is indicated for the The printed package leaflet of the medicinal product must state the name and. Package leaflet: Information for the patient. JEVTANA® 60 mg concentrate and solvent for solution for infusion. cabazitaxel. Read all of this leaflet carefully.
|Published (Last):||13 September 2015|
|PDF File Size:||8.64 Mb|
|ePub File Size:||15.94 Mb|
|Price:||Free* [*Free Regsitration Required]|
You are advised not to father a child during and up to 6 months after treatment and to seek advice on conservation of sperm prior to treatment because JEVTANA may alter male fertility. One ml of concentrate contains 40 mg cabazitaxel.
Common may affect up to 1 in 10 people: JEVTANA can cause a leak in the stomach or intestine, intestinal blockage, infection, and bleeding in the stomach or intestine. You may need to go to the hospital for treatment.
JEVTANA® (cabazitaxel) injection for Advanced Prostate Cancer
Your doctor will calculate your body surface area in square meters m 2 and will decide the dose you should have. Severe allergic reactions can happen within a few minutes after your infusion of JEVTANA starts, especially during the pckage and second infusions.
Do not take any new medicines without asking your HCP first. Pregnancy, breast-feeding and fertility JEVTANA should not be used in pregnant women or women of childbearing age not using contraception. Call your doctor for medical advice about side effects.
Jevtana – Patient Information Leaflet (PIL) – (eMC)
Company contact details Genzyme Therapeutics. How much and how often to have The usual dose depends on your body surface area.
One single use clear glass vial, closed with a grey chlorobutyl rubber closure sealed by an aluminium cap with a light green plastic flip-off cover containing 1. Read all of this leaflet carefully before you start using this medicine because it paciage important information for you.
Very common may affect more than 1 in 10 people: Febrile neutropenia or neutropenic infection. Men who are 65 years or older may be more likely to have Show More. To bookmark a medicine you must sign up and log in. These measures will help to protect the environment.
Adverse Reactions Hematologic Lab Abnormalities. Tell your HCP if: Its common name is “cabazitaxel”. Driving and using machines Cabazitwxel may feel tired or dizzy when having this medicine. You may need to read it again. Tell your HCP if you develop these signs or symptoms: Low white blood cells, which can cause you to get serious infections, and may lead to death.
Dosing and Dose Modifications
Monitoring of complete blood counts is essential on a weekly basis during cycle 1 and before each treatment cycle thereafter so that the dose can be adjusted if needed. This can lead to death. What is a Patient Information Leaflet and why is it useful? Tell your HCP about all the medicines you takeincluding prescription and over-the-counter medicines, vitamins, and herbal supplements. Your doctor may need to treat you.
The expiry date refers to the last day of that month. Frequency not known cannot be estimated from the available data; interstitial lung disease inflammation of the lungs causing coughing and difficulty breathing.
Overall Survival Tumor Response. Sign Up Log In Cancel.
By reporting side effects you can help provide more information on the safety of this medicine. Primary prophylaxis with G-CSF is recommended in patients with high-risk clinical features.
JEVTANA is contraindicated in patients who have a history of severe hypersensitivity reactions to cabazitaxel or to other drugs formulated with polysorbate Severe vomiting and diarrhea with JEVTANA can lead to loss of too much body fluid dehydrationor too much of your body salts electrolytes.